diaDexus, Inc. – ‘8-K’ for 11/20/03

On:  Thursday, 11/20/03, at 11:41am ET   ·   For:  11/20/03   ·   Accession #:  1169232-3-6778   ·   File #:  0-26483

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         4      9K 
 2: EX-99.1     Press Release                                          7     34K 

8-K   —   Current Report
Document Table of Contents

8-K
1st Page of 4
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

----------

FORM 8-K

CURRENT REPORT

 Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 Date of Report (Date of earliest event reported): November 20, 2003

VAXGEN, INC.
(Exact name of Registrant as Specified in its Charter)

    DELAWARE                        0-26483               94-3236309
(State or other jurisdiction of  (Commission File Number)    (I.R.S. Employer   
incorporation or organization)                            Identification Number)

 1000 MARINA BLVD., SUITE 200 BRISBANE, CALIFORNIA 94005
 (Address of Principal Administrative Offices)

  Registrant's Telephone Number, Including Area Code: (650) 624-1000

8-K
2nd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 2nd
Item 7. Financial Statements and Exhibits.                                      

(a)   Financial Statements of Businesses Acquired. Not applicable.  

(b)   Pro Forma Financial Information. Not applicable.              

(c)   Exhibits.                                                     

Exhibit No.       Description                                                   
-----------       -----------                                                   

99.1              Press release issued by VaxGen, Inc. on November 20, 2003     
                  entitled, "VaxGen Announces Increase in Revenue and Decline in
              Losses for Third Quarter; Previously Announced Restatement
Completed with No Impact on Cash Position." 

Item 12. Results of Operations and Financial Condition.                         

On November 20, 2003, VaxGen, Inc. ("VaxGen"), a Delaware corporation, issued a 
press release entitled, "VaxGen Announces Increase in Revenue and Decline in    
Losses for Third Quarter; Previously Announced Restatement Completed with No    
Impact on Cash Position." A copy of this press release is furnished as Exhibit  
99.1 to this report and is incorporated herein by reference.                    

8-K
3rd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 3rd
 SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the        
registrant has duly caused this report to be signed on its behalf by the        
undersigned hereunto duly authorized.                                           

                VaxGen, Inc.
                (Registrant)

Dated: November 20, 2003                                                        
                      By: /s/ Carter Lee
                                         -----------------------------
                      Carter Lee
                                 Senior Vice President
                                    Finance & Administration

8-K
Last Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 4th
 EXHIBIT INDEX

Number                               Description                                
------      --------------------------------------------------------------------
99.1        Press release issued by VaxGen, Inc. on November 20, 2003 entitled, 
       "VaxGen Announces Increase in Revenue and Decline in Losses for
         Third Quarter; Previously Announced Restatement Completed with No
Impact on Cash Position."                               

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on / For Period End:		11/20/03		1		4			None on these Dates
									List all Filings